Pages that link to "Q36569094"
Jump to navigation
Jump to search
The following pages link to Randomized, Double-Blinded, Placebo-Controlled Crossover Trial of Treating Erectile Dysfunction with Sildenafil After Radiotherapy and Short-Term Androgen Deprivation Therapy: Results of RTOG 0215 (Q36569094):
Displaying 17 items.
- Radiotherapy for prostate cancer and sexual health (Q26774266) (← links)
- Interventions to address sexual problems in people with cancer (Q33840155) (← links)
- Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer (Q35022939) (← links)
- Potency preservation following stereotactic body radiation therapy for prostate cancer (Q38158080) (← links)
- Methodological considerations in the design and implementation of clinical trials. (Q38190172) (← links)
- Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer (Q38437266) (← links)
- Sexual function and male cancer (Q38713723) (← links)
- Does tadalafil prevent erectile dysfunction in patients undergoing radiation therapy for prostate cancer? (Q42139970) (← links)
- Influence of vascular comorbidities and race on erectile dysfunction after prostate cancer radiotherapy (Q43168667) (← links)
- Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy (Q43796722) (← links)
- Atorvastatin improves erectile dysfunction in patients initially irresponsive to Sildenafil by the activation of endothelial nitric oxide synthase (Q46904973) (← links)
- Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer (Q51021354) (← links)
- A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer. (Q53116648) (← links)
- Impact of sildenafil on marital and sexual adjustment in patients and their wives after radiotherapy and short-term androgen suppression for prostate cancer (Q83485521) (← links)
- Sildenafil Protects Endothelial Cells From Radiation-Induced Oxidative Stress (Q90492111) (← links)
- Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer (Q96817071) (← links)
- Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials (Q98466227) (← links)